The historic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader market now raises questions about future gains. Alternative versions are eroding patent protection , prompting worries that investing in companies heavily reliant to Viagra's previous influence could be a dangerous decision ,